OC-0383: Reduced cardiac risk in Hodgkin lymphoma patients treated with a full arc VMAT compared to b-VMAT. (April 2018) - Levis, M.; Filippi, A.R.; Fiandra, C.; De Luca, V.; Vella, D.; Bartoncini, S.; Ragona, R.; Ricardi, U.